论文部分内容阅读
在对107例肝细胞癌患名的临床及组织学特点的研究中,作者检测了患者的血清不饱和维生素B_(12)的结合活性(以下简称UBBC)及甲胎蛋白(AFP)含量。发现UBBC 含量的增高主要发生在纤维层性肝癌的患者,并可作为此型肿瘤的一种标记。患者和方法:107例(15～75岁)经组织学证实的肝癌恿者中男87、女20例(中9例曾用过口服避孕
In a study of the clinical and histological features of 107 cases of hepatocellular carcinoma patients, the authors tested the patient’s serum-unsaturated vitamin B12 binding activity (hereinafter referred to as UBBC) and alpha-fetoprotein (AFP) content. It was found that the increase in UBBC content mainly occurs in patients with fibroplasia and can be used as a marker for this type of tumor. Patients and Methods: 107 cases (15 to 75 years old) of liver cancer confirmed by histology were 87 males and 20 females (nine of whom had used oral contraception.